Intravenous pamidronate increases bone density in postmenopausal women previously treated with oral bisphosphonates.

被引：0
|
作者：
Rastelli, A [1 ]
Napoli, N [1 ]
Civitelli, R [1 ]
机构：
[1] Washington Univ, Div Bone & Mineral Dis, St Louis, MO USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared With Bisphosphonates in Postmenopausal Women Previously Treated With Oral Bisphosphonates.
    Miller, P.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, R. B.
    Brown, J. P.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 : S271 - S271
  • [2] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Malouf-Sierra, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Huang, S.
    Chines, A.
    Lems, W.
    Brown, J. P.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (01) : 181 - 191
  • [3] Efficacy and safety of denosumab vs. bisphosphonates in postmenopausal women previously treated with oral bisphosphonates
    P.D. Miller
    N. Pannacciulli
    J. Malouf-Sierra
    A. Singer
    E. Czerwiński
    H.G. Bone
    C. Wang
    S. Huang
    A. Chines
    W. Lems
    J.P. Brown
    Osteoporosis International, 2020, 31 : 181 - 191
  • [4] Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates
    Miller, P. D.
    Pannacciulli, N.
    Brown, J. P.
    Czerwinski, E.
    Nedergaard, B. S.
    Bolognese, M. A.
    Malouf, J.
    Bone, H. G.
    Reginster, J. -Y.
    Singer, A.
    Wang, C.
    Wagman, R. B.
    Cummings, S. R.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (08): : 3163 - 3170
  • [5] Trajectories of Bone Remodeling Markers and Bone Mineral Density during Treatment with Strontium Ranelate in Postmenopausal Women Previously Treated with Bisphosphonates
    Lima, Helisane
    Maia, Juliana
    Bandeira, Francisco
    CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES, 2014, 7 : 7 - 11
  • [6] Pamidronate increases bone mineral density in women with postmenopausal or steroid-induced osteoporosis
    Cauza, E
    Etemad, M
    Winkler, F
    Hanusch-Enserer, H
    Partsch, G
    Noske, H
    Dunky, A
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2004, 29 (05) : 431 - 436
  • [7] A Meta-Analysis of 4 Clinical Trials of Denosumab Compared with Bisphosphonates in Postmenopausal Women Previously Treated with Oral Bisphosphonates
    Miller, Paul D.
    Pannacciulli, N.
    Malouf, J.
    Singer, A.
    Czerwinski, E.
    Bone, H. G.
    Wang, C.
    Wagman, Rachel B.
    Brown, J. P.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [8] Intravenous zoledronic acid 5 mg in the treatment of postmenopausal women with low bone density previously treated with alendronate
    McClung, Michael
    Recker, Robert
    Miller, Paul
    Fiske, Darrell
    Minkoff, Jerome
    Kriegman, Audrey
    Zhou, Wenchun
    Adera, Mathews
    Davis, Jenny
    BONE, 2007, 41 (01) : 122 - 128
  • [9] Role of oral pamidronate in preventing bone loss in postmenopausal women
    Lees, B
    Garland, SW
    Walton, C
    Ross, D
    Whitehead, MI
    Stevenson, JC
    OSTEOPOROSIS INTERNATIONAL, 1996, 6 (06) : 480 - 485
  • [10] Effects of adding intravenous pamidronate to ongoing hormonal therapy on bone mineral density in postmenopausal Korean women
    Yoon, B-K
    Lee, D-Y
    Koo, Y-A
    Min, Y-K
    Park, H-M
    BONE, 2012, 50 : S154 - S154
12345